Joana Prata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joana Prata has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Rui Coelho
I3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal
19 shared publications - Henrique Barros
Universidade do Porto, Portugal
5 shared publications - Amadeu Quelhas Martins
Faculdade de Ciências da Saúde, Universidade Europeia, 1500-210 Lisbon, Portugal
4 shared publications - Sónia Ramos
Cardiovascular Research Unit, Faculty of Medicine, University of Porto, Portugal
4 shared publications Ana Cláudia Fernandes
Trofa Saúde Hospital, Braga Centro / Braga Sul, Portugal
3 shared publications- Elisabete Ramos
EPIUnit – Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal
3 shared publications
Latest Publications
- 5 July 2019
- Published by Springer Nature
- Vol. 2011, 493-510
The Contribution of Inflammation to Autism Spectrum Disorders: Recent Clinical Evidence
Autism comprises a complex and heterogeneous spectrum of neurodevelopmental disorders, usually termed autism spectrum disorders (ASD). It is more prevalent in males than females, and genetic and environmental factors are believed to account in similar percentages to the development of ASD. In recent years, the contribution of inflammation and inflammatory mediators to disease aetiology and perpetuation has been the object of intense research. In this chapter, inflammatory aspects that contribute to ASD are discussed, including abnormal microglia activation and polarization phenotypes, increased systemic levels of pro-inflammatory mediators, and altered patterns of immune cell response to activation stimuli. Also, inflammation in the context of gut microbiome and the impact of inflammation on gender prevalence of ASD are considered. Finally, treatment impact on inflammatory parameters and the potential for use of anti-inflammatory drugs, alone or in combination with antipsychotics, to manage ASD are examined.
- 5 July 2019
- Published by Springer Nature
- Vol. 2011, 493-510
The Contribution of Inflammation to Autism Spectrum Disorders: Recent Clinical Evidence
Autism comprises a complex and heterogeneous spectrum of neurodevelopmental disorders, usually termed autism spectrum disorders (ASD). It is more prevalent in males than females, and genetic and environmental factors are believed to account in similar percentages to the development of ASD. In recent years, the contribution of inflammation and inflammatory mediators to disease aetiology and perpetuation has been the object of intense research. In this chapter, inflammatory aspects that contribute to ASD are discussed, including abnormal microglia activation and polarization phenotypes, increased systemic levels of pro-inflammatory mediators, and altered patterns of immune cell response to activation stimuli. Also, inflammation in the context of gut microbiome and the impact of inflammation on gender prevalence of ASD are considered. Finally, treatment impact on inflammatory parameters and the potential for use of anti-inflammatory drugs, alone or in combination with antipsychotics, to manage ASD are examined.
- Open Access
- 1 May 2019
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 38 (5) , 361-368
Impact of a brief psychological intervention on lifestyle, risk factors and disease knowledge during phase I of cardiac rehabilitation after acute coronary syndrome
- 1 May 2019
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 38 (5) , 361-368
Open AccessImpact of a brief psychological intervention on lifestyle, risk factors and disease knowledge during phase I of cardiac rehabilitation after acute coronary syndrome
- 13 February 2018
- Published by ARC Publishing in International Journal of Clinical Neurosciences and Mental Health
- No. 4
Parent training for parents of children on the autism spectrum: a review
- 13 February 2018
- Published by ARC Publishing in International Journal of Clinical Neurosciences and Mental Health
- No. 4
Parent training for parents of children on the autism spectrum: a review
- Open Access
- 4 September 2017
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 14 (1) , 1-33
Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations
In recent years, evidence supporting a link between inflammation and neuropsychiatric disorders has been mounting. Autism spectrum disorders (ASD) and schizophrenia share some clinical similarities which we hypothesize might reflect the same biological basis, namely, in terms of inflammation. However, the diagnosis of ASD and schizophrenia relies solely on clinical symptoms, and to date, there is no clinically useful biomarker to diagnose or monitor the course of such illnesses. The focus of this review is the central role that inflammation plays in ASD and schizophrenia. It spans from pre-clinical animal models to clinical research and excludes in vitro studies. Four major areas are covered: (1) microglia, the inflammatory brain resident myeloid cells, (2) biomarkers, including circulating cytokines, oxidative stress markers, and microRNA players, known to influence cellular processes at brain and immune levels, (3) effect of anti-psychotics on biomarkers and other predictors of response, and (4) impact of gender on response to immune activation, biomarkers, and response to anti-psychotic treatments.
- 4 September 2017
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 14 (1) , 1-33
Open AccessBridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations
In recent years, evidence supporting a link between inflammation and neuropsychiatric disorders has been mounting. Autism spectrum disorders (ASD) and schizophrenia share some clinical similarities which we hypothesize might reflect the same biological basis, namely, in terms of inflammation. However, the diagnosis of ASD and schizophrenia relies solely on clinical symptoms, and to date, there is no clinically useful biomarker to diagnose or monitor the course of such illnesses. The focus of this review is the central role that inflammation plays in ASD and schizophrenia. It spans from pre-clinical animal models to clinical research and excludes in vitro studies. Four major areas are covered: (1) microglia, the inflammatory brain resident myeloid cells, (2) biomarkers, including circulating cytokines, oxidative stress markers, and microRNA players, known to influence cellular processes at brain and immune levels, (3) effect of anti-psychotics on biomarkers and other predictors of response, and (4) impact of gender on response to immune activation, biomarkers, and response to anti-psychotic treatments.
- Open Access
- 1 September 2017
- Published by Elsevier in Revista Portuguesa de Cardiologia (English Edition)
- Vol. 36 (9) , 641-649
Brief psychological intervention in phase I of cardiac rehabilitation after acute coronary syndrome
- 1 September 2017
- Published by Elsevier in Revista Portuguesa de Cardiologia (English Edition)
- Vol. 36 (9) , 641-649
Open AccessBrief psychological intervention in phase I of cardiac rehabilitation after acute coronary syndrome
- Open Access
- 1 September 2017
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 36 (9) , 641-649
Brief psychological intervention in phase I of cardiac rehabilitation after acute coronary syndrome
- 1 September 2017
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 36 (9) , 641-649
Open AccessBrief psychological intervention in phase I of cardiac rehabilitation after acute coronary syndrome
- Open Access
- 31 May 2017
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 30 (5) , 373-380
Female Psychological Adjustment Following an Acute Coronary Syndrome
Introduction: The outcomes of cardiovascular disease are consistently worse among women, regardless of age or disease severity. Such trend might arise from psychosocial factors, which should be examined in this population. Objective: To evaluate the influence of type-D personality on anxiety and depression symptoms reported by female patients after a first acute coronary syndrome. Material and Methods: As part of a larger study, 34 female patients with a first acute coronary syndrome were compared with 43 controls on psychosocial measures (Hospital Anxiety and Depression Scale; type-D personality, DS - 14). Results: Hypertension (p < 0.001), diabetes (p < 0.05), dyslipidemia (p < 0.05), type-D personality (p = 0.001) and anxiety (p < 0.001) were more prevalent among patients. Exercise (p < 0.05) and antidepressant use (p < 0.05) were more common among controls. Logistic regression analysis confirmed that higher prevalence of hypertension (p < 0.05), dyslipidemia (p < 0.05), type-D personality (p < 0.05), anxiety (p < 0.05) and less antidepressant use (p < 0.05), were independently associated with acute coronary syndrome. Type-D personality was associated with higher Hospital Anxiety and Depression Scale scores in controls (anxiety: p = 0.001; depression: p < 0.001) but not in patients. Discussion: High anxiety after an acute coronary syndrome might reflect a short-term adaptive response, albeit worsening the disease long-term prognosis. The lack of differences in some group comparisons (patients versus controls for depression scores; type-D ‘positive’ versus type-D ‘negative’ for anxiety and depression scores within patients) is discussed. Conclusion: Type-D personality, high anxiety, hypertension and dyslipidemia seem to cluster among female acute coronary syndrome patients. Nevertheless, type-D personality itself was not associated with higher anxiety and depressive scores during the post-acute period.
- 31 May 2017
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 30 (5) , 373-380
Open AccessFemale Psychological Adjustment Following an Acute Coronary Syndrome
Introduction: The outcomes of cardiovascular disease are consistently worse among women, regardless of age or disease severity. Such trend might arise from psychosocial factors, which should be examined in this population. Objective: To evaluate the influence of type-D personality on anxiety and depression symptoms reported by female patients after a first acute coronary syndrome. Material and Methods: As part of a larger study, 34 female patients with a first acute coronary syndrome were compared with 43 controls on psychosocial measures (Hospital Anxiety and Depression Scale; type-D personality, DS - 14). Results: Hypertension (p < 0.001), diabetes (p < 0.05), dyslipidemia (p < 0.05), type-D personality (p = 0.001) and anxiety (p < 0.001) were more prevalent among patients. Exercise (p < 0.05) and antidepressant use (p < 0.05) were more common among controls. Logistic regression analysis confirmed that higher prevalence of hypertension (p < 0.05), dyslipidemia (p < 0.05), type-D personality (p < 0.05), anxiety (p < 0.05) and less antidepressant use (p < 0.05), were independently associated with acute coronary syndrome. Type-D personality was associated with higher Hospital Anxiety and Depression Scale scores in controls (anxiety: p = 0.001; depression: p < 0.001) but not in patients. Discussion: High anxiety after an acute coronary syndrome might reflect a short-term adaptive response, albeit worsening the disease long-term prognosis. The lack of differences in some group comparisons (patients versus controls for depression scores; type-D ‘positive’ versus type-D ‘negative’ for anxiety and depression scores within patients) is discussed. Conclusion: Type-D personality, high anxiety, hypertension and dyslipidemia seem to cluster among female acute coronary syndrome patients. Nevertheless, type-D personality itself was not associated with higher anxiety and depressive scores during the post-acute period.
- 1 September 2016
- Published by Elsevier in Journal of Affective Disorders
- Vol. 201, 162-170
Depression predicts mortality and hospitalization in heart failure: A six-years follow-up study
- 1 September 2016
- Published by Elsevier in Journal of Affective Disorders
- Vol. 201, 162-170
Depression predicts mortality and hospitalization in heart failure: A six-years follow-up study